Freeman Chris

SEC Form 4 insider

Chief Commercial Officer · Guardant Health, Inc. ($GH)

1 thesis · first seen Aug 11, 2026

Window	Theses	Resolved	Wins	Win rate	Avg return	Median return
1d	—	—	—	—	—	—
3d	—	—	—	—	—	—
1w	—	—	—	—	—	—
1m	—	—	—	—	—	—
3m	—	—	—	—	—	—
6m	—	—	—	—	—	—
1y	—	—	—	—	—	—

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$GHSEC Form 4bearish

Freeman Chris · Chief Commercial Officer at Guardant Health, Inc. · 4h agono track record yet

Sold 63,605 @ $169.58 avg · $10,786,111 · 2026-08-10

Form 4: Freeman Chris sold GH

Freeman Chris (Chief Commercial Officer at Guardant Health, Inc.) reported an open-market sale of 63,605 shares of GH at an average $169.58, roughly $10,786,111, in a Form 4 filed 2026-08-11.

1d—

3d—

1w—

1m—

3m—

6m—

1y—

View filing on SEC.gov →

End of results.

Window	Theses	Resolved	Wins	Win rate	Avg return	Median return
1d	—	—	—	—	—	—
3d	—	—	—	—	—	—
1w	—	—	—	—	—	—
1m	—	—	—	—	—	—
3m	—	—	—	—	—	—
6m	—	—	—	—	—	—
1y	—	—	—	—	—	—

Window	Theses	Resolved	Wins	Win rate	Avg return	Median return
1d	—	—	—	—	—	—
3d	—	—	—	—	—	—
1w	—	—	—	—	—	—
1m	—	—	—	—	—	—
3m	—	—	—	—	—	—
6m	—	—	—	—	—	—
1y	—	—	—	—	—	—

Window	Theses	Resolved	Wins	Win rate	Avg return	Median return
1d	—	—	—	—	—	—
3d	—	—	—	—	—	—
1w	—	—	—	—	—	—
1m	—	—	—	—	—	—
3m	—	—	—	—	—	—
6m	—	—	—	—	—	—
1y	—	—	—	—	—	—